Skip to main content
. 2017 Mar 10;4(2):ofx045. doi: 10.1093/ofid/ofx045

Figure 1.

Figure 1.

Projected impact of nucleic acid amplification test (NAAT) on reducing duration of airborne isolation and duration of unnecessary Mycobacterium tuberculosis (MTB) treatment for patients with nontuberculous mycobacteria (NTM). 1 denotes that actual time of discontinuing airborne isolation and stopping MTB treatment. 2 denotes the expected time discontinuing airborne isolation and stopping MTB treatment, if NAAT was not available. AFB, acid-fast bacilli.